Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Turco

Showing results (151-160 of 172) with videos related to

Pageof 18
Sort By:
International Journal for Parasitology|February 22, 2005
Leishmania braziliensis: a novel mechanism in the lipophosphoglycan regulation during metacyclogenesisRodrigo P P Soares, Tatiana L Cardoso, Tamara Barron, et al.
Plos Neglected Tropical Diseases|December 3, 2015
Differential Impact of LPG-and PG-Deficient Leishmania major Mutants on the Immune Response of Human Dendritic CellsMichelle A Favila, Nicholas S Geraci, Asha Jayakumar, et al.
East African Medical Journal|May 6, 2004
Leishmania major-Phlebotomus duboscqi interactions: inhibition of anti-LPG antibodies and characterisation of two proteins with shared epitopesW K Tonui, P M Ngumbi, S S Mpoke, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989
Microbial glycolipids: possible virulence factors that scavenge oxygen radicalsJ Chan, T Fujiwara, P Brennan, et al.
Biochemistry|September 22, 1987
Structure of the major carbohydrate fragment of the Leishmania donovani lipophosphoglycanS J Turco, S R Hull, P A Orlandi, et al.
East African Medical Journal|October 31, 2001
Transmission blocking vaccine studies in leishmaniasis: I. Lipophosphoglycan is a promising transmission blocking vaccine molecule against cutaneous leishmaniasisW K Tonui, P A Mbati, C O Anjili, et al.
East African Medical Journal|October 31, 2001
Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c miceW K Tonui, P A Mbati, C O Anjili, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 10, 1996
Lipophosphoglycan from Leishmania suppresses agonist-induced interleukin 1 beta gene expression in human monocytes via a unique promoter sequenceD E Hatzigeorgiou, J Geng, B Zhu, et al.
The Journal of Biological Chemistry|February 27, 2003
Functional identification of galactosyltransferases (SCGs) required for species-specific modifications of the lipophosphoglycan adhesin controlling Leishmania major-sand fly interactionsDeborah E Dobson, Luella D Scholtes, Kelli E Valdez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1996
Structure-function analysis of Leishmania lipophosphoglycan. Distinct domains that mediate binding and inhibition of endothelial cell functionJ L Ho, H K Kim, P M Sass, et al.
Pageof 18

Showing results (151-160 of 172) with videos related to

Sort By:
Pageof 18
International Journal for Parasitology|February 22, 2005
Leishmania braziliensis: a novel mechanism in the lipophosphoglycan regulation during metacyclogenesisRodrigo P P Soares, Tatiana L Cardoso, Tamara Barron, et al.
Plos Neglected Tropical Diseases|December 3, 2015
Differential Impact of LPG-and PG-Deficient Leishmania major Mutants on the Immune Response of Human Dendritic CellsMichelle A Favila, Nicholas S Geraci, Asha Jayakumar, et al.
East African Medical Journal|May 6, 2004
Leishmania major-Phlebotomus duboscqi interactions: inhibition of anti-LPG antibodies and characterisation of two proteins with shared epitopesW K Tonui, P M Ngumbi, S S Mpoke, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989
Microbial glycolipids: possible virulence factors that scavenge oxygen radicalsJ Chan, T Fujiwara, P Brennan, et al.
Biochemistry|September 22, 1987
Structure of the major carbohydrate fragment of the Leishmania donovani lipophosphoglycanS J Turco, S R Hull, P A Orlandi, et al.
East African Medical Journal|October 31, 2001
Transmission blocking vaccine studies in leishmaniasis: I. Lipophosphoglycan is a promising transmission blocking vaccine molecule against cutaneous leishmaniasisW K Tonui, P A Mbati, C O Anjili, et al.
East African Medical Journal|October 31, 2001
Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c miceW K Tonui, P A Mbati, C O Anjili, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 10, 1996
Lipophosphoglycan from Leishmania suppresses agonist-induced interleukin 1 beta gene expression in human monocytes via a unique promoter sequenceD E Hatzigeorgiou, J Geng, B Zhu, et al.
The Journal of Biological Chemistry|February 27, 2003
Functional identification of galactosyltransferases (SCGs) required for species-specific modifications of the lipophosphoglycan adhesin controlling Leishmania major-sand fly interactionsDeborah E Dobson, Luella D Scholtes, Kelli E Valdez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1996
Structure-function analysis of Leishmania lipophosphoglycan. Distinct domains that mediate binding and inhibition of endothelial cell functionJ L Ho, H K Kim, P M Sass, et al.
Pageof 18